@article {Wilde2022.07.01.22277008, author = {David Chamberlayne Wilde and Sagar Kansara and Lucas Gomez Sapienza and Logan Banner and Rickey Morlen and David Hernandez and Andrew Tsao Huang and Weiyuan Mai and Clifton David Fuller and Stephen Lai and Vlad Constantin Sandulache}, title = {Early detection of mandible osteoradionecrosis risk in a high comorbidity Veteran population}, elocation-id = {2022.07.01.22277008}, year = {2022}, doi = {10.1101/2022.07.01.22277008}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Objective Osteoradionecrosis (ORN) of the mandible is a devastating complication of external beam radiation therapy (EBRT) for head and neck squamous cell carcinoma (HNSCC). We sought to ascertain ORN risk in a Veteran HNSCC population treatment with definitive or adjuvant EBRT and followed prospectively.Study design Retrospective analysis of prospective cohort.Setting Tertiary care Veterans Health Administration (VHA) medical center.Methods Patients with HNSCC who initiated treatment at the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) are prospectively tracked for quality of care purposes through the end of the cancer surveillance period (5 years post treatment completion). We retrospectively analyzed this patient cohort and extracted clinical and pathologic data for 164 patients with SCC of the oral cavity, oropharynx, larynx and hypopharynx who received definitive or adjuvant EBRT (2016-2020).Results Most patients were dentate and 80\% underwent dental extractions prior to EBRT of which 16 (16\%) had complications. The rate of ORN was 3.7\% for oral cavity SCC patients and 8.1\% for oropharyngeal SCC patients. Median time to ORN development was 156 days and the earliest case was detected at 127 days post EBRT completion. All ORN patients were dentate and underwent extraction prior to EBRT start.Conclusion ORN development can occur early following EBRT in a Veteran population with significant comorbid conditions but overall rates are in line with the general population. Prospective tracking of HNSCC patients throughout the post-treatment surveillance period is critical to early detection of this devastating EBRT complication.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis material is the result of work supported with resources and the use of facilities of the Michael E. DeBakey VA Medical Center. VCS is supported by a Career Development Award from the Veterans Administration Clinical Science Research and Development division (1IK2CX001953).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Following approval from Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) Institutional Review Boards, we reviewed the records of patients who were diagnosed and initiated radiation therapy at the MEDVAMC between January 2016 and December 2020 captured in our treatment tracking registry.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.}, URL = {https://www.medrxiv.org/content/early/2022/07/03/2022.07.01.22277008}, eprint = {https://www.medrxiv.org/content/early/2022/07/03/2022.07.01.22277008.full.pdf}, journal = {medRxiv} }